1. Currently enrolled in another research trial for investigative nutritional or other therapies thought to have an impact on immune system functioning. 
2. Unable to consent to the study. 
3. Women who are pregnant or are attempting conception, especially in the presence of a history of recurrent spontaneous abortion. 
4. Other medical complications that might preclude one from participating in the study, i.e., recent heart attack or stroke or chronic kidney disease. 
5. Currently taking immunomodulatory medication, i.e. interferon. 
6. Currently taking other medications thought to have an impact on immune system functioning, i.e., chemotherapeutic agents. 
7. Known allergy to rice, rice bran, or related food products. 
8. Known allergy to mushrooms or related food products. 
9. History of malignancies related to the NK cell line, including: NK cell leukemias and T-cell large granular lymphocyte leukemias, NK-cell lymphoproliferative disease of granular lymphocytes, and NK cell lymphomas, e.g., nasal and nasal-like NK/T-cell lymphomas. 
10. Current smoker.       
    

NCT02019628_exc_T5
Person
Women
NCT02019628_exc_T6
Condition
pregnant
NCT02019628_exc_T7
Condition
spontaneous abortion
NCT02019628_exc_T8
Temporal
recurrent
NCT02019628_exc_T9
Condition
heart attack
NCT02019628_exc_T10
Temporal
recent
NCT02019628_exc_T11
Condition
stroke
NCT02019628_exc_T12
Condition
chronic kidney disease
NCT02019628_exc_T13
Drug
immunomodulatory medication
NCT02019628_exc_T15
Drug
interferon
NCT02019628_exc_T16
Drug
chemotherapeutic agents
NCT02019628_exc_T18
Condition
allergy to rice
NCT02019628_exc_T19
Drug
rice
NCT02019628_exc_T20
Condition
allergy to rice bran
NCT02019628_exc_T21
Drug
rice bran
NCT02019628_exc_T23
Condition
allergy to mushrooms
NCT02019628_exc_T24
Condition
malignancies
NCT02019628_exc_T25
Observation
History
NCT02019628_exc_T26
Qualifier
related to the NK cell line
NCT02019628_exc_T27
Condition
NK cell leukemias
NCT02019628_exc_T28
Condition
T-cell large granular lymphocyte leukemias
NCT02019628_exc_T30
Condition
NK-cell lymphoproliferative disease of granular lymphocytes
NCT02019628_exc_T31
Condition
NK cell lymphomas
NCT02019628_exc_T32
Condition
nasal-like NK/T-cell lymphomas
NCT02019628_exc_T33
Condition
nasal NK/T-cell lymphomas
NCT02019628_exc_T36
Scope
NK cell leukemias and T-cell large granular lymphocyte leukemias, NK-cell lymphoproliferative disease of granular lymphocytes, and NK cell lymphomas, e.g., nasal and nasal-like NK/T-cell lymphomas
NCT02019628_exc_T37
Scope
malignancies related to the NK cell line
NCT02019628_exc_T38
Qualifier
Other
NCT02019628_exc_T39
Condition
medical complications
NCT02019628_exc_T40
Negation
preclude
NCT02019628_exc_T42
Scope
Other medical complications that might preclude one from participating in the study
NCT02019628_exc_T43
Scope
recent heart attack or stroke or chronic kidney disease
NCT02019628_exc_T44
Temporal
Currently
NCT02019628_exc_T45
Qualifier
other
NCT02019628_exc_T46
Drug
medications
NCT02019628_exc_T47
Qualifier
impact on immune system functioning
NCT02019628_exc_T48
Scope
other medications thought to have an impact on immune system functioning
NCT02019628_exc_T49
Condition
allergy to food products
NCT02019628_exc_T50
Temporal
Current
NCT02019628_exc_T51
Observation
smoker